Overview

Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
THVD-201 is a novel combination of a muscarinic antagonist (tolterodine) and a muscarinic agonist (pilocarpine).
Phase:
Phase 1
Details
Lead Sponsor:
TheraVida, Inc.
Treatments:
Pilocarpine
Tolterodine Tartrate